Nearly 1.5 million insulin syringes recalled
Recalled syringes may have graduated markings that are printed incorrectly on the syringe barrel.
The FDA on June 25 announced a class I recall of nearly 1.5 million insulin syringes.
Smiths Medical recalled the Jelco Hypodermic Needle-Pro Fixed Needle Insulin Syringes because the syringes may have graduated markings that are printed incorrectly on the syringe barrel. Specifically, the odd-numbered graduation markings on the syringe barrel may be skewed about 20 degrees upward, potentially leading to an overdose or underdose of insulin.
The recall includes 1,431,000 syringes distributed from Oct. 31, 2020, to Jan. 10, 2021. There have been nine complaints reported for this issue. No injuries or deaths have been reported.